David F Hale insider trades: Oncternal Therapeutics (ONCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 3 more companies
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | ONCT | ↑ Buy | 714 | $9.04 | $6K | Direct | Feb 27, 2024 (4d) |
| Feb 23, 2024 | ONCT | ↑ Buy | 266 | $9.04 | $2K | By Hale BioPharma Ventures, LLC | Feb 27, 2024 (4d) |
| Dec 9, 2021 | BIOC | ↓ Sell | 363 | $4.06 | $1K | By LLC | Dec 10, 2021 (1d) |
| Dec 9, 2021 | BIOC | ↓ Sell | 71 | $4.07 | $289 | Direct | Dec 10, 2021 (1d) |
| Dec 9, 2021 | BIOC | ↓ Sell | 11 | $4.07 | $45 | By trust | Dec 10, 2021 (1d) |
| Jun 30, 2021 | ONCT | ↓ Sell | 3,669 | $4.75 | $17K | By Hale BioPharma Ventures, LLC | Jul 2, 2021 (2d) |
| Jun 12, 2020 | BIOC | ↓ Sell | 556 | $0.56 | $309 | Direct | Jun 12, 2020 (0d) |
| Jun 12, 2020 | BIOC | ↓ Sell | 445 | $0.55 | $247 | By trust | Jun 12, 2020 (0d) |
| Jun 12, 2020 | BIOC | ↓ Sell | 159 | $0.56 | $89 | By LLC | Jun 12, 2020 (0d) |
| Oct 19, 2016 | BIOC | ↑ Buy | 90,909 | $1.10 | $100K | By LLC | Oct 21, 2016 (2d) |
| May 4, 2016 | BIOC | ↑ Buy | 50,000 | $1.00 | $50K | Direct | May 5, 2016 (1d) |
| Feb 13, 2015 | BIOC | ↑ Buy | 40,000 | $1.25 | $50K | By LLC | Feb 18, 2015 (5d) |
| Jul 30, 2013 | CNAT | ↑ Buy | 2,588 | $11.00 | $28K | Indirect | Aug 1, 2013 (2d) |
| Mar 21, 2012 | SNTS | ↑ Buy | 18,000 | $5.34 | $96K | Direct | Mar 22, 2012 (1d) |
| Dec 1, 2010 | SOMX | ↓ Sell | 107,893 | $2.68 | $290K | By Hale Family Trust UTD 2/10/86 | Dec 3, 2010 (2d) |
| Jun 16, 2010 | MITI | ↓ Sell | 30,000 | $7.24 | $217K | By Family Trust | Jun 17, 2010 (1d) |
| Apr 16, 2008 | MBRX | ↑ Buy | 10,000 | $2.34 | $23K | By Family Trust and Hale BioPharma Ventu | Apr 17, 2008 (1d) |
| Jun 22, 2007 | MITI | ↑ Buy | 18,165 | $2.69 | $49K | By LLC | Jun 26, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David F Hale's insider trades
David F Hale is an insider at Oncternal Therapeutics (ONCT). Since Jun 22, 2007, David has reported 9 open-market purchases worth $406K and 9 sales worth $527K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (89 filings), other transactions (11 filings), gifts (11 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.